Our featured speaker for this post is Dr Uwe Gottschalk, Vice President, Purification Technologies, Sartorius Stedim Biotech, Germany. He will be the chairman at Biologic Manufacturing World Asia 2012, part of a series of conferences in the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore.
A short introduction: Dr. Gottschalk is Group Vice President, Purification Technologies, with a global responsibility for bioseparation products at Sartorius Stedim Biotech. He worked in different capacities for Bayer Health Care from 1991-2004 and became head of the GMP protein purification facility in Wuppertal (Germany). He was responsible for the production of monoclonal antibodies and other recombinant proteins using various expression systems. Dr. Gottschalk holds a Ph.D. in Chemistry from the University of MÂnster. He is member of BioPharm International’s editorial advisory board and has written one book, five book chapters and many other publications in the areas of biotechnology and somatic gene therapy. In academia Dr. Gottschalk is Head Lecturer at the University of Duisburg-Essen (Germany) and also lectures at the Ecole Polytechnique Fâ€šdâ€šrale de Lausanne EPFL (Lausanne, Switzerland). Dr. Gottschalk is board member of the VBU Association of German Biotech Companies.
Dr Gottschalk will be addressing us during the Chairman’s opening remarks on day 2 of Biologic Manufacturing World Asia 2012.